Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Apria Inc (APR)

Apria Inc (APR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Apria Healthcare Group Inc. (APR) Q1 2022 Earnings Call Transcript

APR earnings call for the period ending March 31, 2022.

APR : 37.50 (+0.03%)
Apria Announces Financial Results for Fourth Quarter and Full Year 2021

INDIANAPOLIS, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR), a leading provider of integrated home healthcare...

APR : 37.50 (+0.03%)
Apria Announces Expiration of Hart-Scott-Rodino Waiting Period

INDIANAPOLIS, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR), a leading provider of home medical equipment,...

APR : 37.50 (+0.03%)
Is Apria (APR) Stock Outpacing Its Medical Peers This Year?

Here is how Apria (APR) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.

APR : 37.50 (+0.03%)
ATNM : 6.56 (-7.08%)
Company News for Jan 11, 2022

Companies in The News Are: CMC,AZZ,ZNGA,TTWO,APR,OMI

OMI : 24.12 (-2.51%)
TTWO : 143.43 (+0.42%)
AZZ : 73.24 (-11.15%)
CMC : 53.71 (+0.02%)
ZNGA : 8.18 (-2.04%)
APR : 37.50 (+0.03%)
Why Apria Stock Is Skyrocketing Today

News of a big acquisition excited investors.

APR : 37.50 (+0.03%)
OMI : 24.12 (-2.51%)
Apria, Inc. (APR) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Apria, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – APR

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Apria, Inc. (NASDAQ: APR) to Owens & Minor, Inc. for $37.50 per share in cash is fair to Apria shareholders.

APR : 37.50 (+0.03%)
Are These Medical Stocks a Great Value Stocks Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

APR : 37.50 (+0.03%)
HOLX : 75.71 (-1.30%)
Owens & Minor, Inc. Signs Definitive Agreement to Acquire Apria, Inc.

Owens & Minor, Inc. (“Owens & Minor”) (NYSE: OMI) and Apria, Inc. (“Apria”) (Nasdaq: APR) today announced that the companies have entered into a definitive agreement pursuant to which Owens & Minor...

OMI : 24.12 (-2.51%)
APR : 37.50 (+0.03%)
Apria Completes Secondary Offering of Common Stock

INDIANAPOLIS, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR) announced today the completion of a secondary...

APR : 37.50 (+0.03%)

Barchart Exclusives

This Dividend King Is Now One of BofA's Investment Best Ideas
Discover why S&P Global, a seasoned Dividend King, has not only secured a spot on Bank of America's prestigious US 1 List, but also why analysts are bullish about its investment potential in the current economic climate. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar